Institutional Profile: Translational Pharmacogenomics at the Icahn School of Medicine at Mount Sinai
Stuart A. Scott(Stanford Health Care), Eric E. Schadt(Program for Appropriate Technology in Health), Judy H. Cho(Cedars-Sinai Medical Center), Mariana Rodrigues Botton(Sema4 (United States)), George A. Díaz(Icahn School of Medicine at Mount Sinai), Erick R. Scott(Sema4 (United States)), Kurt Hirschhorn(Icahn School of Medicine at Mount Sinai), Andrew Kasarskis(Icahn School of Medicine at Mount Sinai), Joel T. Dudley(Hamilton Thorne (United States)), Eimear E. Kenny(Rockefeller University), Paola Nicoletti(University of Florence), Stephen B. Ellis(Leukemia and Lymphoma Society), Inga Peter(Icahn School of Medicine at Mount Sinai), Aniwaa Owusu Obeng(Icahn School of Medicine at Mount Sinai), Pamela Sklar(Allen Institute for Brain Science), Richard Wallsten(Sema4 (United States)), Erwin P. Böttinger(Regeneron (United States)), Xiang Zhou(Shenzhen Institutes of Advanced Technology), Jean‐Sébastien Hulot(Inserm), Tom Kaszemacher(Icahn School of Medicine at Mount Sinai), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Robert J. Desnick(Icahn School of Medicine at Mount Sinai), Rong Chen(Wuhan Institute of Bioengineering), Yao Yang(Sema4 (United States)), Aida Vega(Icahn School of Medicine at Mount Sinai), Lisa Edelmann(Sema4 (United States)), Eva Waite(Icahn School of Medicine at Mount Sinai), Hetanshi Naik(Stanford University)
Cited by 21
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k